UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Dr Stefan Trapp
422
Rockefeller Building
Bloomsbury Campus
London
WC1E
Appointment
  • Reader in Autonomic Neuroscience and Metabolic Disease
  • Neuro, Physiology & Pharmacology
  • Div of Biosciences
  • Faculty of Life Sciences
Biography

Dr Trapp is Reader in Autonomic Neuroscience and Metabolic Disease and, together with Professor Alexander Gourine, heads the UCL Center for Cardiovascular and Metabolic Neuroscience (CCMN) . He trained as a biologist at the Carl von Ossietzky University in Oldenburg, Germany. He obtained his PhD at the Georg August University in Goettingen, Germany, with studies on the cellular physiology of vagal neurons and the first description of ATP-sensitive potassium channels in autonomic neurons. Dr Trapp then relocated as a DFG-Fellow to Oxford in order to study the molecular properties of these channels in detail with Prof Frances Ashcroft, FRS. Subsequently, he obtained a Career Development Award from the MRC and established the Autonomic Lab, first at University College London, and then at Imperial where he became a Lecturer in 2006 and Senior Lecturer in 2008. Dr Trapp joined UCL's Department of Neuroscience, Physiology & Pharmacology in 2013.

Research Themes
Research Summary

The research in our lab aims at a greater understanding of the role of the brain in metabolic disease, particularly diabetes mellitus, obesity, and co-morbidities such as autonomic dysfunction. Supported primarily by the MRC and recently also the EFSD and Diabetes UK, we are using transgenic models combined with pharmacogenetics, and a combination of molecular, optical, immunocytochemical and electrophysiological techniques to address these questions in vitro and in vivo. Over the years our work has been concerned with metabolic regulation of neuronal excitability under physiological and pathophysiological conditions. This ranges from the mechanisms underlying ischemic and anaesthetic preconditioning, via molecular mechanisms of glucosensing in the vagal nucleus, to the role of glucagon-like-peptide (GLP)-1 secreting neurones in the brainstem.

Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by